Table 3 Characteristics of participants depending on symptoms profile. Categorical variables are reported as counts (percentages) and quantitative variables as median [Q1–Q3]
Cluster #1 (n = 1011) | Cluster #2 (n = 2103) | Cluster #3 (n = 68) | Cluster #4 (n = 65) | |||||
|---|---|---|---|---|---|---|---|---|
Symptoms | ||||||||
Taste or smell disorder | 0 | (0%) | 628 | (30%) | 68 | (100%) | 2 | (3%) |
Respiratory | 0 | (0%) | 1147 | (55%) | 0 | (0%) | 0 | (0%) |
Digestive | 0 | (0%) | 730 | (35%) | 0 | (0%) | 65 | (100%) |
Systemic | 0 | (0%) | 1639 | (78%) | 0 | (0%) | 0 | (0%) |
Fatigue | 0 | (0%) | 1125 | (53%) | 5 | (7%) | 15 | (23%) |
Rhinorrhea | 0 | (0%) | 1002 | (48%) | 26 | (38%) | 0 | (0%) |
Characteristics | ||||||||
Women | 705 | (70%) | 1458 | (69%) | 46 | (68%) | 49 | (75%) |
Age | 48 | 41–64 | 47 | 40–59 | 56 | 42–70 | 46 | 38–55 |
ELISA-S | 1.8 | 1.4–2.8 | 2.2 | 1.5–3.6 | 2.6 | 1.6–4.1 | 1.8 | 1.3–2.4 |
ELISA-NP | 0.6 | 0.4–1.1 | 1.0 | 0.5–2.4 | 2.0 | 1.0–2.8 | 0.5 | 0.4–0.8 |
SN | 10 | 10–20 | 10 | 10–80 | 40 | 20–160 | 10 | 10–10 |